|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 4 of 4
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Yamamoto, Gaku; Asahina, Hajime; Honjo, Osamu; Sumi, Toshiyuki; Nakamura, Atsushi; Ito, Kenichiro; Kikuchi, Hajime; Hommura, Fumihiro; Honda, Ryoichi; Yokoo, Keiki; Fujita, Yuka; Oizumi, Satoshi; Morita, Ryo; Ikezawa, Yasuyuki; Tanaka, Hisashi; Kimura, Nozomu; Sasaki, Takaaki; Sukoh, Noriaki; Takashina, Taichi; Harada, Toshiyuki; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi | First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | - | Scientific reports | - | 30-Nov-2021 |
article (author version) | Ito, Shotaro; Asahina, Hajime; Honjo, Osamu; Tanaka, Hisashi; Honda, Ryoichi; Oizumi, Satoshi; Nakamura, Keiichi; Takamura, Kei; Hommura, Fumihiro; Kawai, Yasutaka; Ito, Kenichiro; Sukoh, Noriaki; Yokoo, Keiki; Morita, Ryo; Harada, Toshiyuki; Takashina, Taichi; Goda, Tomohiro; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi | Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902) | - | Lung cancer | - | Jun-2021 |
article (author version) | Takashina, Taichi; Asahina, Hajime; Oizumi, Satoshi; Yamada, Noriyuki; Harada, Masao; Takamura, Kei; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Ogi, Takahiro; Morikawa, Naoto; Kinoshita, Ichiro; Honda, Ryoichi; Nakano, Kosuke; Kanazawa, Kenya; Amano, Toraji; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101) | - | International journal of clinical oncology | - | Dec-2018 |
article | Takashina, Taichi; Kinoshita, Ichiro; Kikuchi, Junko; Shimizu, Yasushi; Sakakibara-Konishi, Jun; Oizumi, Satoshi; Nishimura, Masaharu; Dosaka-Akita, Hirotoshi | Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells | - | Cancer science | - | Jul-2016 |
Showing results 1 to 4 of 4
|